Latest from Dan L. Duncan

Tannaz Armaghany, MD, discusses the importance of NCI-MATCH trial in colorectal cancer.
Benjamin Leon Musher, MD, discusses sequencing challenges and research efforts needed regarding immunotherapy in hepatocellular carcinoma before it becomes a standard approach for patients.
OncLive interviewed experts at the State of the Science Summits™ in February 2020 on common misconceptions in their respective fields.
Investigators are exploring concurrent PARP inhibition and definitive regional radiotherapy in patients with metastatic invasive cervical cancer in an ongoing phase I/II study.
Ghanshyam Yadav, MD, discusses the differences between type 1 and type 2 uterine cancer. 
The group of researchers is conducting the largest African-American prostate cancer study ever, aiming to include 10,000 men nationwide.
Baylor College of Medicine has been awarded more than $17.4 million by the Cancer Prevention & Research Institute of Texas to support new cancer research and programs, core facilities and recruitment of new faculty.
Shoba A. Navai, MD, an assistant professor, Department of Pediatrics, Section of Pediatric Hematology and Oncology, at Baylor College of Medicine, Texas Children’s Hospital, discusses treatment options for patients with relapsed/refractory sarcoma.
Publication Bottom Border
Border Publication